Arcus Biosciences (RCUS) EBT Margin Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 813.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -35,294.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,294.00 |
| Dec 31, 2025 | 3,648.00 |
| Sep 30, 2025 | -32,756.00 |
| Mar 31, 2025 | -39,724.00 |
| Dec 31, 2024 | 21,374.00 |
| Sep 30, 2024 | 2,396.00 |
| Jun 30, 2024 | 1,671.00 |
| Mar 31, 2024 | 30,924.00 |
| Dec 31, 2023 | -37,437.00 |
| Sep 30, 2023 | -1,866.00 |
| Jun 30, 2023 | -702.00 |
| Mar 31, 2023 | 6,022.00 |
| Dec 31, 2022 | -27,645.00 |
| Sep 30, 2022 | 62,720.00 |
| Jun 30, 2022 | 55,483.00 |
| Mar 31, 2022 | 39,506.00 |
| Dec 31, 2021 | 64,919.00 |
| Sep 30, 2021 | -82,700.00 |
| Jun 30, 2021 | 177,268.00 |
| Mar 31, 2021 | 81,860.00 |